Postmortem studies of the brains of Alzheimer's patients show a dramatic destruction of neurons, and particularly neurons which secrete or utilise the neurotransmitter acetylcholine.
Not exact matches
Specifically, intensive
postmortem neurological
studies of their
brain tissues reveal a relatively low density
of acetylcholine (a neurotransmitter) nerve sites, which, at normal densities, function in critical ways to help re-initiate breathing following a sleep - related apnea or extended breathing pauses.
A
study published online last November in
Brain, based on the most comprehensive collection
of postmortem images compiled to date, shows that Einstein's cerebral cortex, responsible for higher - level mental processes, differs much more dramatically than previously thought from that
of a person
of average intelligence.
Studies have reported altered methylation patterns in
postmortem brains of people with autism.
In a
study reported in Nature, Collinge and colleagues found A-beta buildup in four
of eight
postmortem brains from people who had received growth hormone injections
A recent generation
of studies of postmortem brain tissue from people with schizophrenia, particularly from the laboratory
of Professor David Lewis and his colleagues at the University
of Pittsburgh, have shed light on schizophrenia - related abnormalities in the interplay
of the main excitatory neurons, pyramidal neurons, and a specific class
of inhibitory nerve cells, called chandelier cells, in the prefrontal cortex.
A recent human
study also indicated a genetic association
of the αCaMKII gene with bipolar disorder, and decreased expression
of αCaMKII has been observed in
postmortem brains of patients with bipolar disorder.
However, the neural basis
of early overgrowth remains unknown and can only be known from direct quantitative
studies of the young
postmortem autistic
brain.
Dr. Sonntag
studies this concept on the molecular and cellular level using a translational research approach that integrates the analysis
of human material, such as
postmortem brains, primary cell systems, and neural cell populations generated from patients» - or healthy individuals» - derived induced pluripotent stem cells (iPSC), or induced neurons (iNs), in combination with molecular, biochemistry, and lentivirus - mediated gene - engineering technologies.
In this context, Dr. Woo's work focuses on deepening the understanding
of these mechanisms based on
postmortem human
brains and animal
studies using a variety
of protein and gene expression techniques, in addition to the utilization
of differentiated human neurons.
Numerous
studies on
postmortem brains have found evidence
of infection, such as biofilms, in the same regions as Alzheimer's neurodegeneration — namely, the hippocampus and temporal lobe (1).
Postmortem studies show lower than normal levels
of BDNF in the
brains of people with Alzheimer's.
Several
postmortem studies report the presence
of inflammatory markers in the
brains of depressed or mood - disordered patients.
This ability makes stem cell - driven research a good complement to
studies of postmortem brains.
Studies of postmortem brain tissue will lead the way to better prevention and treatment
of autism spectrum and related neurodevelopmental disorders.
«With
postmortem research, we're
studying brain circuits and the molecules and cells that support these circuits — the potential targets
of new drugs,» said Dr. Woo.
A
postmortem brain study showed that the emergence
of structural connectivity moved generally from posterodorsal to anteroventral regions in infants aged between 17 to 40 weeks post-conception [47].